Table 1.
Disease | Metabolic change | Functional change | Ref. |
---|---|---|---|
Asthma | ↑ HO-1 | ROS production | 83 |
↑ ROS | Lung injury, TNF-α, IL-1β production | 80,82 | |
↑ 15-LOX | 5-HETE and leukotrienes | 239 | |
↑ Leukotriene B4/E4 | Bronchial constriction, AHR | 85–87 | |
↑ Prostaglandin E2 | ↓ AM phagocytosis | 78 | |
↑ FAO gene expression (CPT) | ↑ FAO metabolism | 84 | |
↑ Glycolysis function PKM2 | HIF1a dependent gene expression | ||
↑ Arg1, ↓ NOS2 | Ornithine and proline | 89,90 | |
COPD | ↑ ROS, ↑ mtROS, ↑ Superoxide | Oxidative stress | 108–110 |
↓ mtROS after challenge | Impaired bacterial clearance | 108 | |
↓ Glutamyl cysteine ligase | Loss of GSH synthesis | 111 | |
↑ iNOS | NO production | 117 | |
↓ Mt membrane potential | Impaired phagocytosis | 114 | |
↑ Iron sequestration | ROS generation | 113 | |
↑ HIF1α | ↑ Glycolysis | 119 | |
↓ Compensatory glycolysis | Unmet energetic demand | 7 | |
↓ Coupling efficiency, ↓ OXPHOS ↑ Proton leak |
Dysfunctional metabolism and macrophage phenotype | 7 | |
↑ A2BR | ↑ Adenosine metabolism | 118 | |
CF | ↑ Arginase | Impaired phagocytosis & efferocytosis | 132 |
↑ ROS release, ↓ GSH | Oxidative stress | 136,137 | |
↓ Superoxide, ↓ NOX phos. | ↓ Oxidative burst | 141 | |
↓ Lipoxin A4 | ↓ Anti-inflammatory potential | 147 | |
↑ Acod11 | Persistent P. Aeruginosa infection | 143 | |
↓ CFTR-PTEN complex | ROS production, succinate release | 144 | |
↑ Iron | ↑ ROS production | 138 | |
↑ IRE-a pathway | Increased glycolysis & Mt. function | 149 | |
IPF | ↑ ROS | Oxidative stress | 175 |
↑ Secreted Rac1 | NOX, superoxide, mTOR activation | 178,179 | |
↑ iNOS | NO and OONO- production | 181,182 | |
↓ HO-1 | Loss of oxidative response | 240 | |
↑ Iron uptake | Oxidative stress & ROS | 184,185 | |
↓ % of CD71+ AM | Accumulation of transferrin | 186 | |
↑ AKT | Activation of HIF1α | 241 | |
↑ GLUT-1, ↑ Glucose uptake | NADPH production, superoxide | 166–168 | |
↑ Glycolysis, glycolysis genes | M2-like AM profile | 166 | |
↑ FAO | 166 | ||
↑ MCU, ↑ Calcium, ↑ PGC-1α | FAO reprogramming, mtROS | ||
TB | ↑ ROS/RNS production | Bacterial killing | 208 |
↑ HIF1a | Aerobic glycolysis, IFN-γ host defence | 210 | |
Warburg shift, ↑ glycolysis genes | ↑ IL-1β and bacterial killing | 211,215 | |
↑ Host MiR-21 | ↓ Glycolytic response, ↑ bacterial survival | 215 | |
↑ Host MiR-33 | ↓ autophagy, FAO, ↓ host defence | 224 | |
↓ Hydrogen sulphide | ↑ Glycolysis & PPP | 214 | |
↑ fumarate | Bactericidal | 216 | |
↑ itaconate | Antimicrobial, modulates host response | 217 | |
Heparin ↓ Hepcidin | Decreased iron availability to bacilli | 206 | |
↑ Iron, superoxide, lipid perox. | Ferroptosis, bacterial spread | 220 | |
↑ FAO, ↑ Lipid accumulation | ↑Host response, ↓ Bacterial burden | 223,242 | |
PPAR-α activation | FAO, autophagy & host defence | 222 | |
↑ IDO, ↑ tryptophan | ↓ host defence | 225 | |
↑ Glutaminolysis | ↑ cytokine profile | 243 | |
↑ Arg1 | NO production | 244 | |
↑ NAD+, creatine, GSH | Host defence | 245 |
aUpward arrow represents increased expression, downward arrow represents decreased expression.